Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4D1A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $73,243
Award facts
- Contract value 100% obligated
- $73,243.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, valued at $73,243.37 for the supply of XELJANZ XR 11 mg tablets in quantities of 30-count units. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the performing location for this order, which is scheduled for completion by December 10, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
This delivery order supports the Defense Logistics Agency's Medical Supply Chain, which provides pharmaceutical products to military healthcare systems and other federal customers. XELJANZ XR is a brand-name immunosuppressive medication used in the treatment of rheumatoid arthritis and other inflammatory conditions. AmerisourceBergen's comprehensive IDC vehicle enables the company to supply a broad range of pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems globally. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive federal medical procurement requirements across varying order values and product types.
Quick answers
Who was awarded contract SPE2DR26F4D1A?
SPE2DR26F4D1A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F4D1A worth?
The government has obligated $73,243 on SPE2DR26F4D1A.
Is contract SPE2DR26F4D1A an order under another contract?
Yes. SPE2DR26F4D1A is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4D1A competed?
The extent of competition for SPE2DR26F4D1A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award